Joseph M. O’Malley, Jr. is the global chair of the Intellectual Property practice at Paul Hastings, overseeing the firm's 100-plus lawyer IP practice. He has extensive patent litigation experience across a broad range of technologies, including chemicals and pharmaceuticals. Mr. O'Malley has served as lead trial counsel for many branded pharmaceutical clients including Pfizer, Merck, Abbott, Eisai, Sunovion (formerly Sepracor), and Takeda (formerly Nycomed), and has prevailed at trial and appeal in billion-dollar-a-year Hatch-Waxman Act pharmaceutical patent litigations.
Paul Hastings Recognized in 2019 IAM Patent 1000 as One of the Most Sophisticated Patent Litigation Practices
June 07, 2019
Paul Hastings Practices and Lawyers Score Top Rankings in Chambers USA 2019
May 01, 2019
Paul Hastings Wins Top Honors at 2019 Managing IP Americas Awards
April 08, 2019
Paul Hastings Scores Top Rankings in LMG Life Sciences for 2018
October 11, 2018
Paul Hastings Wins Hatch-Waxman Litigation Firm of the Year at LMG Life Sciences Awards
September 13, 2018
Paul Hastings Recognized in 2018 Managing Intellectual Property IP Stars
June 18, 2018
Paul Hastings Recognized in 2018 IAM Patent 1000 For Superb Track Record in Patent Litigation
June 15, 2018
Paul Hastings Practices and Lawyers Score Top Rankings in Chambers USA 2018
May 11, 2018
Paul Hastings Wins Law360 Life Sciences Practice Group of the Year
February 05, 2018
Yar Chaikovsky Named Law360 Technology MVP
December 28, 2017
Paul Hastings Recognized For Pristine Patent Litigation Track Record in 2017 IAM Patent 1000
August 08, 2017
Paul Hastings Practices and Lawyers Score Top Rankings in Chambers USA 2017
June 05, 2017
Paul Hastings Intellectual Property Practice Continues Leadership in PTAB Filings
February 09, 2017
Paul Hastings Scores Top Rankings in LMG Life Sciences for 2016
November 30, 2016
Joseph O’Malley Named Law360 Intellectual Property MVP
November 23, 2016
Paul Hastings’ Litigators Score High Rankings in 2017 Benchmark Litigation
October 21, 2016
Paul Hastings’ IP Growth Continues with Leading Tech and Life Sciences Partner Additions in Japan and U.S.
July 06, 2016
Paul Hastings Practices and Lawyers Score Top Rankings in Chambers USA 2016
June 08, 2016
Paul Hastings Practices and Lawyers Score Top Rankings in Chambers USA 2015
May 20, 2015
Nationally Recognized Technology Patent Trial Team Join Paul Hastings in Palo Alto and Washington, D.C.
March 30, 2015
Paul Hastings Practices and Lawyers Score Top Rankings in Chambers USA 2014
May 27, 2014
Paul Hastings Life Sciences Practice Recognized as a Law360 Practice Group of the Year 2013
January 15, 2014
Paul Hastings Extensive Practice Strength Highlighted in The Legal 500 United States 2013
June 05, 2013
Paul Hastings Employment Practice Honored with Chambers ''Award for Excellence'' and Firms Leading Practices and Lawyers Ranked in Chambers USA 2013
May 27, 2013
Paul Hastings Excels in Chambers USA 2012 Guide
June 07, 2012
Paul Hastings Prevails on All Arguments in Intellectual Property Defense of Galderma Laboratories
May 31, 2012
Paul Hastings Invalidates Five Patents and Eliminates Alleged Damages for Sunovion
March 12, 2012
Paul Hastings Excels in Chambers USA 2011 Guide
June 10, 2011
Paul Hastings Soars in 2011 Edition of Legal 500 US
June 01, 2011
Paul Hastings Garners Top Rankings in Chambers USA 2010 Guide
June 14, 2010
Paul Hastings Excels in 2010 Edition of Legal 500 US
June 07, 2010
Paul Hastings Secures Dismissal in Patent Infringement Case on Behalf of Eisai
September 10, 2009
Patent Litigators Secure Final Victory for Eisai Against Generic Drugmakers
July 22, 2008
Paul Hastings Obtains Preliminary Injunction in a Patent Infringement Case on Behalf of Eisai
March 28, 2008
Paul Hastings Earns Top Marks in the Latest Volume of The Legal 500 US
June 19, 2007
Paul Hastings Attorneys Recognized as Super Lawyers in Southern California, Connecticut, Georgia, New York, San Diego and Washington, D.C.
May 20, 2007
Paul Hastings Wins Patent Trial for Eisai Pharmaceuticals
May 14, 2007
Paul Hastings Obtains Summary Judgment for Major Pharmaceutical Company
November 06, 2006
Paul Hastings Bolsters International IP Practice With Addition of Prominent Patent Litigation Lawyers in New York
September 12, 2006
Federal Circuit Again Affirms Patent-Ineligibility of Diagnostic Method Claims: Key Takeaways from the Athena v. Mayo Decision
February 12, 2019
Federal Circuit Reverses Judge Sleet’s Factual Findings for Failure to Address Unrebutted Evidence
November 03, 2017
Generic Found to Infringe Valid Patent Claims Covering Helsinn’s Aloxi® Product
February 21, 2017
District of Delaware Finds Specific Jurisdiction Exists Over an ANDA Filer in the Context of a Hatch-Waxman Case
November 06, 2014
District of New Jersey Prevents Generic Challenger from Using Claim Construction as a Backdoor to Introduce Barred Invalidity Defense
June 16, 2014
In an Issue of First Impression, the Federal Circuit Finds Infringement as a Matter of Law Despite a Sworn Certification Promising No Infringement
September 26, 2013
The Federal Circuit Further Clarifies The Obviousness-Type Double Patenting Doctrine For Composition Claims
August 27, 2012
Defendants Clinical Trial Found to Constitute Invalidating Public Use of Asserted Patents
March 02, 2012
A Sign of Future Biosimilars Litigation?
November 21, 2011
Federal Circuit Significantly Tightens Doctrine of Inequitable Conduct Today in Its En Banc Therasense Ruling
May 25, 2011
Failure to Launch
April 07, 2011
Federal Circuit Vacates Injunction Against Generic Drug Manufacturer, Determining That A Settlement Agreement Term Is Ambiguous
December 29, 2010
District of Delaware Allows Generic Drug Manufacturers to Carve Out Two AstraZeneca Patents Claiming FDA-Approved Uses of Crestor
December 20, 2010
District of New Jersey Resets KUDCos ANDAs Final Approval in Protonix Litigation, Notwithstanding Outstanding Defenses of Teva and Sun
August 19, 2010
Generic Drug Manufacturers Inequitable-Conduct Defenses Dismissed for Failing to Meet Exergens Stringent Pleading Standard
June 08, 2010
Patent Owner Protected by Safe Harbor Provision
January 27, 2010
New District of New Jersey Local Patent Rules Require Early Action in Pharmaceutical Patent Cases
January 07, 2009
Proposed Changes to Federal Rules on Experts
October 28, 2008
Recognized by Managing IP as the Life Sciences IP Litigation Firm of the Year
Paul Hastings was was recognized by Managing IP at their Americas Awards, which honored individuals and companies behind the most innovative and challenging IP work of the past year, as well as those driving the international IP market.
The firm was recognized as Life Sciences IP Litigation Firm of the Year in the United States.
April 05, 2019
Recognized by Chambers Global 2019
Chambers Global 2019: The World’s Leading Lawyers listed the firm in 37 research areas and named 59 firm lawyers to its rankings of leading lawyers and law firms adept in complex international work and with strong cross-border capabilities.
February 14, 2019
Recognized as the 2019 Post-Grant Firm of the Year by IAM Magazine
Paul Hastings was recognized as the Post-Grant Firm of the Year at Intellectual Asset Management's inaugural Global IP Awards. The award recognizes the achievements of the firm's Patent Trial and Appeal Board (PTAB) Team, which practices before the US Patent & Trial Office. Over the past year, the team's accomplishments include numerous post-grant proceeding victories for technology and life sciences clients - four of which were affirmed by the Court of Appeals for the Federal Circuit.
January 30, 2019
Recognized as LMG Life Sciences Stars for 2018
Paul Hastings was recognized in the 2018 edition of LMG Life Sciences, with Highly Recommended rankings for General Patent Litigation and Hatch-Waxman Branded Litigation. LMG Life Sciences selected seven individual lawyers as "Life Sciences Stars," including Eric Dittmann, Gary Giampetruzzi, Naveen Modi, Joseph O’Malley, Chad Peterman, Preston Ratliff, and Bruce Wexler. Earlier this year, LMG Life Sciences honored the firm with the LMG Life Sciences award for Hatch-Waxman Litigation Firm of the Year – Branded.
October 12, 2018
Recognized as the Hatch-Waxman Litigation Firm of the Year by LMG Life Sciences
LMG Life Sciences announced that the firm’s Intellectual Property practice was honored at the LMG Life Sciences Awards as the Hatch-Waxman Litigation Firm of the Year (Branded). The publication cited the firm for wins on behalf of Sunovion Pharmaceuticals, which locked in compound patent protection for Latuda®, the company’s billion-dollar-plus-per-year schizophrenia and bipolar drug, after a judgment of infringement that was affirmed by the Federal Circuit; and for Orexigen Therapeutics after a trial victory where the judge found all three patents-in-suit to be valid and infringed. The firm was also noted for obtaining an unprecedented six walk-away consent judgments in a major pharmaceutical litigation.
The firm and its partners were also shortlisted for:
* Inter-Partes Review Firm of the Year
* Post Grant Proceedings Attorney of the Year: Naveen Modi
* General Patent Litigator of the Year – New York: Bruce Wexler
September 13, 2018
Recognized by Chambers USA 2018
Chambers USA 2018: America’s Leading Lawyers for Business listed the firm in 45 research areas and named 112 firm lawyers to its rankings of leading lawyers and law firms in the United States.
May 15, 2018
Recognized as Law360 Practice Group of the Year in Life Sciences
Paul Hastings was named as a Practice Group of the Year in Life Sciences by Law360. The article noted Paul Hastings’ undefeated track record in life sciences cases at the Patent Trial and Appeal Board, including victories on behalf of Acorda Therapeutics, which won four inter partes reviews against Kyle Bass’ Coalition for Affordable Drugs. Law360 also highlighted the representation of Galena Biopharma in a civil-only settlement resolving investigations regarding Galena’s past promotional practices for Abstral, a rapid onset opioid product. The winners were chosen from nearly 750 submissions, and are recognized as "firms that racked up victories in litigation and closed the big deals to make their mark among clients and throughout the legal industry."
February 01, 2018
Recognized as LMG Life Sciences Stars for 2017
Paul Hastings was recognized in LMG Life Sciences, with Highly Recommended rankings for General Patent Litigation and Hatch-Waxman Branded Litigation.
LMG Life Sciences selected seven individual lawyers as "Life Sciences Stars," including Joseph O’Malley, Bruce Wexler, Gerald Flattmann, Naveen Modi, Chad Peterman, Eric Dittmann, and Gary Giampetruzzi.
October 06, 2017
2017 National Law Journal Intellectual Property Trailblazers
Joseph O’Malley was named an Intellectual Property
Trailblazer by the National Law Journal,
and profiled for his work on behalf of Helsinn Healthcare.
Paul Hastings IP Practice Honored in 2017 IAM Patent 1000
Intellectual Asset Management highlighted Paul Hastings' IP practice in IAM Patent 1000: The World's Leading Patent Professionals. The guide ranked the firm's practices Nationwide as well as in New York and Washington, DC. Paul Hastings partners were ranked in California: Yar Chaikovsky; New York: Joseph O'Malley; Gerald Flattmann; Preston Ratliff; Bruce Wexler; Samuel Waxman; Washington DC: Naveen Modi; Blair Jacobs; Joseph Palys; and Allan Soobert; and in Japan: Hiroyuki Hagiwara.
Paul Hastings attorneys were also recognized in IAM's Nationwide tables: Yar Chaikovsky and Blair Jacobs were recommended for International Trade Commission litigation; Jacobs was recommended for his experience in Federal Circuit appellate litigation; and Naveen Modi and Joseph Palys were both recognized for their strength in post-grant proceedings. Preston Ratliff was also noted in the IAM Strategy 300, which recognizes individuals for their work in protecting intellectual property as a key business asset.
June 06, 2017
Recognized by Chambers USA 2017
Chambers USA 2017: America’s Leading Lawyers for Business named 46 of the firm’s practice areas and 112 individuals to its ranking of leading lawyers and law firms in the United States.
June 05, 2017
Recognized as LMG Life Sciences Stars for 2016
Paul Hastings was recognized in LMG Life Sciences, with Highly Recommended rankings for General Patent Litigation and Hatch-Waxman Branded Litigation. LMG Life Sciences selected six individual lawyers as "Life Sciences Stars," including Joseph O’Malley, Bruce Wexler,
Gerald Flattmann, Gary Giampetruzzi, Naveen Modi, and Eric Dittmann.
November 30, 2016
Law360 MVP Awards 2016: Intellectual Property
Joseph O’Malley was named an MVP award winner by Law360
in the Intellectual Property category. Law360 reviewed more than
1,000 submissions, selecting attorneys with “successes in high-stakes
litigation, record-breaking deals and complex global matters” as this year’s
MVP award winners.
Benchmark Litigation 2017
Benchmark Litigation recognized Yar Chaikovsky, Gerald Flattmann, Douglas Flaum, Holly House, Joseph O'Malley, Barry Sher, Peter Stone, William Sullivan, Bruce Wexler, William K. Whitner, and Thomas Zaccaro as Litigation Stars in its 2017 guide, which focuses exclusively on litigation in the United States. The guide is the result of six months of research, including extensive interviews with litigators and
clients as well as a close examination of recent casework handled by the firm. The firm was ranked in Tier 1 for U.S. Intellectual Property and as Highly Recommended in California.
October 21, 2016
Recognized at the 2016 LMG Life Sciences Awards
Paul Hastings was recognized with multiple LMG Life Sciences Awards. Bruce Wexler was named “General Patent Litigator of the Year – New York” and Naveen Modi was recognized as Post Grant Proceedings Attorney of the Year. The Life Sciences Patent Litigation practice also won awards for two Hatch-Waxman Impact Cases of the Year, including Helsinn Healthcare SA v. Teva Pharmaceuticals USA, a win resolving a long-running patent dispute over Aloxi®, a drug used to treat chemotherapy-induced nausea and vomiting.
The Paul Hastings team representing Helsinn was led by Joseph O’Malley. The firm was also honored for its work on behalf of Eli Lily in Sanofi-Aventis US v. Eli Lilly & Co., where Bruce Wexler led the team representing Eli Lily in litigation regarding the marketing of Basaglar®, its insulin glargine drug product. The case was settled in late 2015, with the press reporting Eli Lilly’s ability to launch the drug.
September 16, 2016
Shortlisted for four LMG Life Sciences Awards for 2016
The Firm was shortlisted in four categories for the LMG Life Sciences Awards. Joseph O’Malley was nominated in the Hatch-Waxman Litigator of the Year – Branded category, Bruce Wexler was nominated in the General Patent Litigator of the Year - New Yorkcategory, Naveen Modi was nominated in the Post Grant Proceedings Attorney of the Year category, and the Firm was nominated in the “Hatch-Waxman Litigation Firm of the Year – Branded” category.
July 27, 2016
Recognized by Chambers USA 2016
Chambers USA 2016: America’s Leading Lawyers for Business named 47 of the firm’s practice areas and 112 individuals to its ranking of leading lawyers and law firms in the United States.
June 08, 2016
Paul Hastings IP Practice Honored in 2016 IAM Patent 1000
Intellectual Asset Management highlighted Paul Hastings' IP practice in its IAM Patent 1000: The World’s Leading Patent Professionals 2016. The guide ranked the firm’s Nationwide, New York, Washington, D.C., and Georgia IP practices; and partners Yar Chaikovsky, Gerald Flattmann, Blair Jacobs, Robin McGrath, Naveen Modi, Joseph O'Malley, Joseph Palys, Preston Ratliff, Samuel Waxman, and Bruce Wexler were recognized as leading lawyers.
May 27, 2016
Benchmark Litigation 2016
Benchmark Litigation recognized Yar Chaikovsky, Gerald Flattmann, Douglas Flaum, Holly House, Joseph O'Malley, Barry Sher, Peter Stone, William Sullivan, Bruce Wexler, and William K. Whitner as Litigation Stars in its 2016 guide, which focuses exclusively on litigation in the United States and is the result of six-months of research that includes extensive interviews with litigators, clients and a close examination of recent casework handled by the firm. The firm was ranked as Highly Recommended in California, and in Tier 2 for US Intellectual Property.
Additionally, the firm was shortlisted for the 2016 Benchmark Litigation US Awards in the State Firm Awards – California category, and Yar Chaikovsky was shortlisted in the Practice Area Attorneys of the Year – Intellectual Property category.
Paul Hastings IP Practice Honored in 2015 IAM Patent 1000
Intellectual Asset Management highlighted Paul Hastings' IP practice in its IAM
Patent 1000: The World’s Leading Patent Professionals 2015. The guide ranked the firm’s Nationwide, New York, and Washington, D.C. IP practices; and partners Yar Chaikovsky, Gerald Flattmann, Blair Jacobs, Naveen Modi, Joseph O'Malley, Steven Park, Jeff Randall, Preston Ratliff, Allan Soobert, and Bruce Wexler were recognized as leading lawyers.
June 17, 2015
Managing IP's 2015 IP Stars
Yar Chaikovsky, Gerald Flattmann, Blair Jacobs, Chris Kennerly, Naveen Modi, Joseph O'Malley, and Bruce Wexler were named 2015 IP Stars by Managing Intellectual Property magazine. Nationwide, the firm's Intellectual Property practice was ranked in the Bio/Life Sciences, Copyright, and Patent Contentious categories. In New York, the firm was ranked Highly Recommended in the Patent Contentious category, and in California, the firm was ranked Recommended in the Copyright and Patent Contentious categories.
May 15, 2015
Paul Hastings Lawyers Honored by Law360 with MVP Wins
O’Malley and Thomas
Zaccaro were each named as MVP award winners by top-tier legal publication
Law360 based on their “success in high-stakes litigation, record-breaking deals
and complex global matters earned.” Michael Fitzgerald was recognized in the
Capital Markets category for his innovative FIBRA work and for advising on the
largest equity offerings in Mexico this year. Joseph O’Malley was recognized in
the Life Sciences category for his numerous litigation victories for
pharmaceutical companies including a patent infringement win for Sunovion that
made new law. And Thomas Zaccaro was recognized in the White Collar category
for innovative defense work in the technology and financial services sectors
and his successful defense of Manouch Moshayedi in one of the largest insider
trading cases ever brought by the U.S. Securities and Exchange Commission.
Law360 chose the 2014 MVPs out of over 800 submissions and it is one of the
legal publication’s most prestigious recognitions.
November 20, 2014
Recognized by LMG Life Sciences for Life Sciences IP Litigation
Paul Hastings' Life Sciences Intellectual Property practice received the highest possible ranking in Legal Media Group’s Life Sciences 2014 guide; as it was ranked “Highly Recommended” in the Hatch-Waxman Patent Litigation (Branded) and General Patent Litigation categories. Commentary from the guide singled out Joseph O’Malley and Bruce Wexler as “preeminent litigators in the industry” and pointed out Gerald Flattmann’s "ability to serve as lead counsel in important industry cases." The IP practice was also described as having “outstanding teams both for commercial patent litigation as well as in dealing with infringement suits on the branded Hatch-Waxman front.”
October 09, 2014
Paul Hastings Intellectual Property Practice Honored in IAM Patent 1000
Intellectual Asset Management highlighted Paul Hastings
IP practice in its 2014 Patent 1000 guide to the top patent practitioners. The guide
ranked the firm’s Nationwide and New York IP practices; and partners Gerald
Soobert and Bruce
Wexler were recognized as leading patent lawyers.
Managing IP's 2014 Intellectual Property Stars
Jeff Randall, Joseph O'Malley, Gerald Flattmann, Bruce Wexler, Melanie Rupert and Christopher Kennerly were named 2014 IP Stars by Managing Intellectual Property magazine. Nationwide, the firm's Intellectual Property practice was
ranked in the Bio/Life Sciences, Copyright and Patent Contentious categories. In New York, the firm's IP practice was ranked
Highly Recommended in the Patent Contentious category and in California, the IP
practice was ranked Recommended in the Copyright and Patent Contentious
Legal Media Group's 2013 LMG Life Science Awards
The firm was nominated as a 2013 LMG Life Science nominee in the “Litigation Team of the Year” and “(General) Patent Litigation: Firm of the Year” categories.
August 12, 2013
Intellectual Asset Management, IAM
Paul Hastings' New York and Nationwide IP practices were ranked in Intellectual Asset Management's IAM Patents 1000, a guide that identifies the top patent practitioners in key jurisdictions around the globe. Additionally, Joseph O'Malley, Jeff Randall, Matthew Berger (for Licensing), Gerald Flattmann, Allan Soobert and Bruce Wexler were singled out for distinction.
June 12, 2012
Intellectual Asset Management
Paul Hastings was recognized in Intellectual Asset Management's 2011 IAM 250: Patent Litigation survey. New York partners Joe O'Malley, Bruce Wexler and Gerald Flattmann were recognized individually in the patent litigation (overall) and life sciences categories. Palo Alto partner Jeff Randall was also recognized individually in the California patent litigation (overall) category.
May 01, 2011
Intellectual Property Magazine
Intellectual Property Magazine recognized Paul Hastings' IP Pharmaceutical Team as the Pharmaceutical Team of the Year.
November 30, 2010
Recognized by Chambers USA 2008
Paul Hastings Soars in Chambers USA 2008 Rankings
June 13, 2008